GGrantIndex
← Search

PILOT--CANCER CONTROL

$0P30FY2001CANIH

Wake Forest University, Winston Salem NC

Investigators

Linked publications, trials & patents

Trial NCT07614022Trial NCT07324577Trial NCT07322367Trial NCT07282444Trial NCT07203534Trial NCT07196241Trial NCT07175376Trial NCT07119489Trial NCT07046936Trial NCT06945042Trial NCT06709404Trial NCT06654245Trial NCT06480591Trial NCT06441266Trial NCT06340503Trial NCT05984680Trial NCT05934851Trial NCT05877404Trial NCT05854966Trial NCT05825066Trial NCT05796518Trial NCT05696782Trial NCT05692635Trial NCT05597878Trial NCT05395936Trial NCT05309655Trial NCT05242770Trial NCT05212272Trial NCT05204290Trial NCT05030038Trial NCT04897217Trial NCT04858269Trial NCT04797884Trial NCT04677816Trial NCT04659993Trial NCT04623515Trial NCT04586127Trial NCT04526080Trial NCT04495751Trial NCT04485026Trial NCT04454489Trial NCT04430335Trial NCT04415944Trial NCT04375384Trial NCT04337580Trial NCT04327700Trial NCT04266470Trial NCT04253964Trial NCT04217317Trial NCT04174742Trial NCT04173247Trial NCT04111107Trial NCT04040244Trial NCT04037527Trial NCT03998189Trial NCT03987568Trial NCT03987555Trial NCT03982537Trial NCT03963739Trial NCT03958747Trial NCT03929211Trial NCT03890614Trial NCT03880526Trial NCT03874065Trial NCT03870529Trial NCT03870451Trial NCT03868943Trial NCT03867175Trial NCT03861091Trial NCT03861065Trial NCT03796273Trial NCT03746262Trial NCT03741868Trial NCT03741829Trial NCT03740035Trial NCT03681405Trial NCT03662074Trial NCT03529565Trial NCT03520283Trial NCT03505762Trial NCT03505736Trial NCT03505671Trial NCT03379376Trial NCT03374995Trial NCT03370159Trial NCT03188432Trial NCT03152786Trial NCT03148080Trial NCT03139435Trial NCT03122743Trial NCT03087591Trial NCT03032250Trial NCT02971410Trial NCT02971397Trial NCT02949843Trial NCT02835222Trial NCT02835066Trial NCT02832154Trial NCT02827838Trial NCT02747407

Abstract

The overall goal of the Cancer Control Program is to develop, test, and disseminate interventions designed to reduce the incidence, morbidity, and mortality of cancer. A total of 23 members are in the program with $2.55 million in annual direct funding from NIH (48% overall peer reviewed funding from NCI) and $4.1 peer reviewed funding. During the period 1996-1999, the program members published 163 manuscripts that have significantly contributed to national cancer control efforts. The specific aims of the program are to: a) test the efficacy of pharmacologic and behavioral interventions to reduce the incidence of cancer; b) examine ways to improve the use of validates early detection tests; c) explore molecular and genetic risk factors for cancer; and d) examine and develop interventions for issues cancer survivors face. To achieve the specific aims of the program, three foci of research have been established: prevention, early detection, and survivorship. Prevention research includes intermediate endpoints of cancer development, risk promoting behaviors and markers of risk in single and multi-center studies. In addition, health policy implications for prevention strategies are being examined. Early detection studies focus on unique populations of the region (e.g, African-Americans, Native Americans, elderly, low-income, rural) utilize multiple behavioral theories in developing interventions, and are community-based Research into survivorship issues includes appropriate health-related quality of life assessments, multi-center studies, and is guided by input from cancer survivors. In all areas, there is evidence of strong intra- and inter- programmatic collaboration. In addition, there is a Cancer Prevention Training Grant within the program that affords post-doctoral fellows the opportunity to work with leaders in the field of Cancer Control Research. These features have assisted in developing a strong research portfolio in cancer control that is making a unique and important contribution to cancer research. Over the next 5 years, the program will continue research in the established foci. In addition, program members will: 1) work with basic science program members to test promising chemoprevention compounds in prevention studies (e.g., soy and Vitamin D); 2) focus on ways to improve the use of early detection exams for colorectal cancer; and 3) develop and test interventions to ameliorate problems faced by long-term cancer survivors. New areas of growth will include genetics and program delivery (e.g., health services research). Surveillance and monitoring of cancer control efforts using existing databases will be further developed and used to assist in evaluating the effects of community-based research projects.

View original record on NIH RePORTER →